Alex Dregan1, Lauren Rayner1, Katrina A S Davis1, Ioannis Bakolis2,3, Jorge Arias de la Torre1, Jayati Das-Munshi1, Stephani L Hatch1, Robert Stewart1,4, Matthew Hotopf1,4. 1. Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom. 2. Biostatistics and Health Informatics, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom. 3. Centre for Implementation Science, Health Services and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom. 4. South London and Maudsley NHS Foundation Trust, London, United Kingdom.
Abstract
Importance: Previous research has linked a history of depression with arterial stiffness (AS) during midlife. Objective: To assess the association of depression with elevated midlife AS and to investigate the extent to which this association is mediated via metabolic syndrome (MetS). Design, Settings, and Participants: This population-based retrospective cohort study analyzed data collected between March 2006 and December 2010 from 124 445 participants aged 40 to 69 years from the UK Biobank. Participants without data on AS at baseline (n = 332 780) or who reported a previous diagnosis of cardiovascular disease (n = 45 374) were not eligible. Data analysis was performed from May to August 2019. Exposures: Lifetime history of depression was assessed via verbal interview and linked hospital-based clinical depression diagnosis. Metabolic syndrome was defined as the presence of 3 or more of hypertension, dyslipidemia, hyperglycemia, hypertriglyceridemia, and unhealthy waist circumference. Main Outcomes and Measures: Peripherally assessed AS index (ASI) using digital photoplethysmography. Results: Of 124 445 included participants with ASI assessed, 71 799 (57.7%) were women, and the mean (SD) age was 56 (8) years. A total of 10 304 participants (8.3%) reported a history of depression. Study findings indicated a significant direct association between depression and ASI levels (β = 0.25; 95% CI, 0.17-0.32). A significant indirect association was also observed between depression and ASI levels (β = 0.10; 95% CI, 0.07-0.13), indicating that 29% of the association of depression with ASI was mediated by MetS. The proportion of mediation increased to 37% when C-reactive protein was added to the MetS criteria (direct association: β = 0.21; 95% CI, 0.15-0.28; indirect association: β = 0.13; 95% CI, 0.10-0.17). Concerning components of MetS, the strongest indirect association was for waist circumference, accounting for 25% of the association between depression and ASI levels (direct association: β = 0.26; 95% CI, 0.18-0.34; indirect association: β = 0.09; 95% CI, 0.06-0.11). Among men, hypertriglyceridemia accounted for 19% of the association between depression and ASI (direct association: β = 0.22; 95% CI, 0.05-0.40; indirect association: β = 0.05; 95% CI, 0.02-0.08). Conclusions and Relevance: One-third of the association of depression with elevated ASI levels during midlife may be accounted for by combined MetS and inflammatory processes. Unhealthy waist circumference and hypertriglyceridemia emerged as the most important potential targets for preventive interventions within women and men, respectively.
Importance: Previous research has linked a history of depression with arterial stiffness (AS) during midlife. Objective: To assess the association of depression with elevated midlife AS and to investigate the extent to which this association is mediated via metabolic syndrome (MetS). Design, Settings, and Participants: This population-based retrospective cohort study analyzed data collected between March 2006 and December 2010 from 124 445 participants aged 40 to 69 years from the UK Biobank. Participants without data on AS at baseline (n = 332 780) or who reported a previous diagnosis of cardiovascular disease (n = 45 374) were not eligible. Data analysis was performed from May to August 2019. Exposures: Lifetime history of depression was assessed via verbal interview and linked hospital-based clinical depression diagnosis. Metabolic syndrome was defined as the presence of 3 or more of hypertension, dyslipidemia, hyperglycemia, hypertriglyceridemia, and unhealthy waist circumference. Main Outcomes and Measures: Peripherally assessed AS index (ASI) using digital photoplethysmography. Results: Of 124 445 included participants with ASI assessed, 71 799 (57.7%) were women, and the mean (SD) age was 56 (8) years. A total of 10 304 participants (8.3%) reported a history of depression. Study findings indicated a significant direct association between depression and ASI levels (β = 0.25; 95% CI, 0.17-0.32). A significant indirect association was also observed between depression and ASI levels (β = 0.10; 95% CI, 0.07-0.13), indicating that 29% of the association of depression with ASI was mediated by MetS. The proportion of mediation increased to 37% when C-reactive protein was added to the MetS criteria (direct association: β = 0.21; 95% CI, 0.15-0.28; indirect association: β = 0.13; 95% CI, 0.10-0.17). Concerning components of MetS, the strongest indirect association was for waist circumference, accounting for 25% of the association between depression and ASI levels (direct association: β = 0.26; 95% CI, 0.18-0.34; indirect association: β = 0.09; 95% CI, 0.06-0.11). Among men, hypertriglyceridemia accounted for 19% of the association between depression and ASI (direct association: β = 0.22; 95% CI, 0.05-0.40; indirect association: β = 0.05; 95% CI, 0.02-0.08). Conclusions and Relevance: One-third of the association of depression with elevated ASI levels during midlife may be accounted for by combined MetS and inflammatory processes. Unhealthy waist circumference and hypertriglyceridemia emerged as the most important potential targets for preventive interventions within women and men, respectively.
Authors: Adrie Seldenrijk; Nicole Vogelzangs; Hein P J van Hout; Harm W J van Marwijk; Michaela Diamant; Brenda W J H Penninx Journal: J Psychosom Res Date: 2010-03-19 Impact factor: 3.006
Authors: Tené T Lewis; Kim Sutton-Tyrrell; Brenda W Penninx; Nicole Vogelzangs; Tamara B Harris; Georgeta D Vaidean; Hilsa N Ayonayon; Lauren Kim; Edward G Lakatta; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2010-06-03 Impact factor: 6.053
Authors: Adrie Seldenrijk; Hein P J van Hout; Harm W J van Marwijk; Eric de Groot; Johan Gort; Cees Rustemeijer; Michaela Diamant; Brenda W J H Penninx Journal: World J Biol Psychiatry Date: 2011-07-11 Impact factor: 4.132
Authors: Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield Journal: Arch Intern Med Date: 2003-02-24
Authors: Ilan S Wittstein; David R Thiemann; Joao A C Lima; Kenneth L Baughman; Steven P Schulman; Gary Gerstenblith; Katherine C Wu; Jeffrey J Rade; Trinity J Bivalacqua; Hunter C Champion Journal: N Engl J Med Date: 2005-02-10 Impact factor: 91.245
Authors: Álvaro Camacho; Robyn L McClelland; Joseph A Delaney; Matthew A Allison; Bruce M Psaty; Dena E Rifkin; Stephen R Rapp; Moyses Szklo; Murray B Stein; Michael H Criqui Journal: J Clin Psychopharmacol Date: 2016-08 Impact factor: 3.153
Authors: Małgorzata Tąpolska; Maciej Spałek; Urszula Szybowicz; Remigiusz Domin; Karolina Owsik; Katarzyna Sochacka; Damian Skrypnik; Paweł Bogdański; Maciej Owecki Journal: Int J Environ Res Public Health Date: 2019-07-17 Impact factor: 3.390
Authors: Julianne D van der Berg; Coen D A Stehouwer; Hans Bosma; Jeroen H P M van der Velde; Paul J B Willems; Hans H C M Savelberg; Miranda T Schram; Simone J S Sep; Carla J H van der Kallen; Ronald M A Henry; Pieter C Dagnelie; Nicolaas C Schaper; Annemarie Koster Journal: Diabetologia Date: 2016-02-02 Impact factor: 10.122
Authors: Jorge Arias-de la Torre; Amy Ronaldson; Matthew Prina; Faith Matcham; Snehal M Pinto Pereira; Stephani L Hatch; David Armstrong; Andrew Pickles; Matthew Hotopf; Alex Dregan Journal: Lancet Healthy Longev Date: 2021-12
Authors: Amy Ronaldson; Jorge Arias de la Torre; Matthew Prina; David Armstrong; Jayati Das-Munshi; Stephani Hatch; Rob Stewart; Matthew Hotopf; Alexandru Dregan Journal: Lancet Reg Health Eur Date: 2021-06-22